false
0001847064
0001847064
2026-11-05
2026-11-05
0001847064
psqh:ClassCommonStockParValue0.0001PerShareMember
2026-11-05
2026-11-05
0001847064
psqh:RedeemableWarrantsEachWholeWarrantExercisableForOneShareOfClassCommonStockAtExercisePriceOf172.50PerShareMember
2026-11-05
2026-11-05
iso4217:USD
xbrli:shares
iso4217:USD
xbrli:shares
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT
REPORT
PURSUANT TO SECTION 13 OR 15(d) OF
THE
SECURITIES EXCHANGE ACT OF 1934
Date of Report (Date of earliest event reported):
November 5, 2026
PSQ
Holdings, Inc.
(Exact name of registrant as specified in its
charter)
| Delaware |
|
001-40457 |
|
86-2062844 |
(State or other jurisdiction
of incorporation) |
|
(Commission File Number) |
|
(I.R.S. Employer
Identification Number) |
| 515 Aspen Street, Suite 200C | | |
| Bozeman, Montana | | 59715 |
| (Address of principal executive offices) | | (Zip Code) |
Registrant’s telephone number, including
area code: (754) 264-8701
(Former name or former address, if changed since
last report)
Check the appropriate box below if the Form 8-K
filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
| ¨ | Written
communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
| ¨ | Soliciting
material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
| ¨ | Pre-commencement
communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
| ¨ | Pre-commencement
communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Securities registered pursuant to Section 12(b) of
the Act:
| Title
of each class |
|
Trading
Symbol(s) |
|
Name
of each exchange
on which registered |
| Class A
common stock, par value $0.0001 per share |
|
PSQH |
|
New
York Stock Exchange |
| Redeemable warrants, each whole warrant exercisable for 1/15 of one
share of Class A common stock at an exercise price of $172.50 per share |
|
PSQH.WS |
|
New
York Stock Exchange |
Indicate by check mark whether the registrant
is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2
of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company x
If an emerging growth company, indicate by check
mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting
standards provided pursuant to Section 13(a) of the Exchange Act.
Item 1.01. Entry into a Material Definitive Agreement.
On November 5, 2026 (the “Closing
Date”), PSQ Holdings, Inc. (the “Company”), through its wholly owned subsidiaries EveryLife, Inc. and EveryLife Women,
LLC (“EveryLife”), completed the sale (the “Transaction”) of certain of the Company’s assets that comprise
EveryLife, a direct-to-consumer diaper and baby products brand, to FreeHold Brands, LLC, a Wyoming limited liability company (“Buyer”),
pursuant to an Asset Purchase Agreement, dated July 28, 2025 (as amended, the “Purchase Agreement”), by and between EveryLife
and Buyer. These assets include, but are not limited to, EveryLife’s inventory, tangible personal property, e-commerce storefronts
and digital accounts, customer and subscriber data, business records, related intellectual property, and certain contracts assigned to
the Buyer.
On the Closing Date, EveryLife
and Buyer entered into a second amendment to the Purchase Agreement (the “Second Amendment”) providing for an adjustment to
the purchase price, pursuant to which the Company received $1.0 million in cash and a $4.5 million seller note issued by the Buyer (the
“Seller Note”). The Seller Note is secured by EveryLife’s assets, begins to accrue interest at the prime rate on February
1, 2027, and provides for a minimum monthly principal payment of $83,333, with any remaining principal due in full 12 months from the
Closing Date (the “Maturity Date”), unless Buyer exercises one or both of its two successive options to extend the Maturity
Date by 12 months per extension if, despite commercially reasonable efforts, Buyer is unable to obtain bank financing sufficient to repay
the Seller Note.
The foregoing descriptions
of the Purchase Agreement, the Second Amendment, and the Seller Note (together, the “Transaction Documents”) are a summary,
do not purport to be complete, and are qualified by reference to the full text of the Transaction Documents. Copies of the Purchase Agreement,
the Second Amendment, and the Seller Note are filed as Exhibits 10.1, 10.3 and 10.4, respectively, to this Current Report on Form 8-K,
and are incorporated herein by reference.
The Transaction Documents
are described herein to provide investors with information regarding the terms of the Transaction. The representations, warranties and
covenants contained in any Transaction Document were made solely for the purposes of such Transaction Document; were made only as of specified
dates and do not reflect subsequent information; were made solely for the benefit of the parties thereto; may be subject to limitations
agreed upon by the contracting parties, including being qualified by confidential disclosures that modify, qualify and create exceptions
to such representations, warranties and covenants; were made for the purposes of allocating risk between the parties thereto instead of
establishing matters of fact; and may be subject to standards of materiality applicable to the contracting parties that differ from those
applicable to investors. Investors are not third-party beneficiaries under the Transaction Documents and should not rely on the representations,
warranties and covenants or any descriptions thereof as characterizations of the actual state of facts or condition of the parties, their
affiliates or their respective businesses. Moreover, information concerning the subject matter of representations and warranties is subject
to change after the date hereof, which subsequent information may or may not be reflected in the Company’s public disclosures.
Item 2.01. Completion of Acquisition or Disposition
of Assets.
The information in Item 1.01
of this Current Report on Form 8-K is incorporated by reference into this Item 2.01.
Item 7.01. Regulation FD Disclosure.
On
November 5, 2026, the Company issued a press release announcing the closing of the Transaction. The press release is furnished as Exhibit
99.1 to this Current Report on Form 8-K and incorporated into this Item 7.01 by reference.
Item 9.01. Financial Statements and Exhibits.
(d) Exhibits
EXHIBIT INDEX
| Exhibit |
|
Description |
| |
|
|
| 10.1* |
|
Asset Purchase Agreement, dated as of July 28, 2026, by and among EveryLife Inc., EveryLife Women, LLC and FreeHold Brands, LLC (incorporated herein by reference to the Company’s Current Report on Form 8-K filed on July 31, 2026). |
| |
|
|
| 10.2 |
|
First Amendment to Asset Purchase Agreement, dated as of September 15, 2026, by and among EveryLife Inc., EveryLife Women, LLC and FreeHold Brands, LLC. |
| |
|
|
| 10.3* |
|
Second Amendment to Asset Purchase Agreement, dated as of November 5, 2026, by and among EveryLife Inc., EveryLife Women, LLC and FreeHold Brands, LLC. |
| |
|
|
| 10.4 |
|
Non-Negotiable Secured Promissory Note, issued by FreeHold Brands, LLC to EveryLife Inc. and EveryLife Women, LLC, dated November 5, 2026 |
| |
|
|
| 99.1 |
|
Press Release dated November 5, 2026 |
| |
|
|
| 104 |
|
Cover Page Interactive Data File (embedded within the Inline XBRL document) |
* Pursuant to Item 601(a)(5) of Regulation
S-K, the exhibits and schedules to Exhibit 10.1 and 10.3 have been omitted and will be furnished supplementally to the Securities and
Exchange Commission upon request.
SIGNATURES
Pursuant to the requirements
of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto
duly authorized.
| |
PSQ Holdings, Inc. |
| |
|
| Date: November 5, 2026 |
By: |
/s/ James Giudice |
| |
Name: |
James Giudice |
| |
Title: |
Chief Legal Officer |
Exhibit 99.1

PSQ Holdings
Completes Sale of EveryLife to FreeHold Brands
Transaction completes
the Company’s transition to a focused fintech business; proceeds to strengthen the balance sheet and fund growth initiatives
BOZEMAN, Mont.,
-- November 5, 2026 -- PSQ Holdings, Inc. (NYSE: PSQH) (the “Company”) today announced that it has completed the previously
announced sale of EveryLife, its direct-to-consumer baby products business, to FreeHold Brands for total consideration of $5.5 million,
subject to customary adjustments.
“Closing
the EveryLife sale completes our move to fintech,” said Dusty Wunderlich, Chairman and Chief Executive Officer. “Every dollar
we invest, and every hour our team works, now goes exclusively toward the merchants and customers who rely on us for payments and financing.
EveryLife has a good home with FreeHold Brands.”
The Company intends
to use the proceeds to strengthen its balance sheet and fund growth initiatives across its fintech businesses. The sale is the final
step in the Company’s effort over the last 12 months to refocus its core business on fintech offerings. With the transaction closed,
the Company operates exclusively in payments and consumer financing.
The consideration
consisted of $1.0 million in cash paid at closing and a $4.5 million promissory note secured by EveryLife's assets. Additional terms
are described in the Company’s Current Report on Form 8-K filed with the Securities and Exchange Commission.
About PSQ Holdings, Inc.
PSQ Holdings (NYSE:
PSQH) is a payments and financial infrastructure company. We build and operate payments and consumer financing infrastructure in highly
regulated environments for industries underserved by traditional financial institutions, including businesses, campaigns, and nonprofits
that depend on reliable, compliant solutions.
Forward-Looking Statements
This press release
contains “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section
21E of the Securities Exchange Act of 1934, as amended, and the safe harbor provisions of the Private Securities Litigation Reform Act
of 1995. Forward-looking statements can generally be identified by words such as “will,” “expects,” “anticipates,”
“intends,” “plans,” “believes,” “estimates,” “targets,” and similar expressions.
Statements in this release regarding the repayment of the promissory note issued by FreeHold Brands, the anticipated use of proceeds
from the sale of EveryLife, the Company’s expectation of achieving positive monthly operating cash flow in 2027, the sufficiency
of the Company’s liquidity to fund its operations, and the Company’s strategy, focus, and growth prospects are forward-looking
statements. These statements are based on management’s current expectations and are subject to risks, uncertainties, and changes
in circumstances that could cause actual results to differ materially. These include the risk that the Company does not achieve positive
operating cash flow when expected, that its cash resources prove insufficient to fund its operations, and that FreeHold Brands does not
obtain financing or does not repay the note when due, in which case the Company’s recovery would depend on enforcement of its security
interest and the value of the collateral. Other risks are described under “Risk Factors” in the Company’s Annual Report
on Form 10-K for the fiscal year ended December 31, 2025 and its subsequent filings with the Securities and Exchange Commission. Except
as required by law, the Company undertakes no obligation to update any forward-looking statement.
Investor Contact:
investment@publicsq.com
Media Contact:
pr@publicsq.com